drugset / Trial / NCT05232344

Sexual Intercourse and Vaginal Absorption of Progesterone

NCT05232344

NaSingle-groupOpen-labelTreatment

Summary

The objective of this project is to compare the vaginal absorption of progesterone administered in the vaginal ovum by measuring progesteroneemia in 3 situations (or "sexual event"): abstinence, sex protected by condoms and unprotected sex.

Timeline

Start
2022-04-13
Primary completion
2024-02-05
Completion
2024-02-29

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Progesterone Other / unclassified 400 mg Other
Background Estradiol Other / unclassified 3 mg

Indications